Megan Priestley, Postdoc Fellow at Terri Brodeur Breast Cancer Foundation, shared a post on LinkedIn:
“I am delighted to share the news that I have been awarded a Cancer Research Institute (CRI) Irvington postdoctoral fellowship! Starting next year, this fellowship will fund the next 3 years of my research examining how aberrant glycosylation contributes to immune evasion in cancer.
I’m deeply grateful to CRI for their support, and would also like to thank the Terri Brodeur Breast Cancer Foundation (TBBCF) for supporting my first two years as a postdoctoral fellow.
I’m excited to continue this work in Jessica Stark’s lab at the MIT Koch Institute for Integrative Cancer Research and in close collaboration with Omer Yilmaz’s lab. Incredibly grateful to Jessica and Omer for their mentorship and support – looking forward to the next few years!”
Other articles about Cancer Research Institute (CRI) on OncoDaily.